Low-dose rituximab every 6 months for the treatment of acetylcholine receptor-positive refractory generalized myasthenia gravis

Lu, J; Zhong, HH; Jing, SS; Wang, L; Xi, JY; Lu, JH; Zhou, L; Zhao, CB

Zhao, CB (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China.

MUSCLE & NERVE, 2020; 61 (3): 311

Abstract

Introduction In this prospective, open-label study we explore the effectiveness of low-dose rituximab every 6 months in treating refractory generalize......

Full Text Link